Submitted by Anonymous (not verified) on 27 September 2024 - 12:33
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 14, Status: Authorised